2011 annual financial data

Corcept Therapeutics 2011 Net margin

Corcept Therapeutics 2011 net margin with verified reported values.

Direct answer

Net margin was Not calculable.

Operating income was -32,332,000 USD and net income was -32,354,000 USD.
Operating cash flow was -27,400,000 USD.

Get free Corcept Therapeutics email updates.

Bullstory sends one daily email when new analysis or important company news is available.

Verified data

Revenue
0 USD
Operating income
-32,332,000 USD
Net income
-32,354,000 USD
Operating cash flow
-27,400,000 USD